FDA Clears ESC Medical's Systemfor Dark-Skin Hair Removal
NEEDHAM, Mass., Mar. 1 -- ESC Medical Systems announced that the US Food and Drug Administration (FDA) has cleared the company's proprietary Intense Pulsed Light (IPL) technology for use in removing hair from skin type VI, or the darkest skin types, including black skin. Yacha Sutton, ESC Medical's CEO, commented, This represents a major breakthrough and is the second FDA clearance received for our IPL technology in less than a month.
Franklin Johnson, a lead investigator in the clinical study of the IPL system on skin type VI, said that prior to this FDA action, dark-complexioned patients had few options for the removal of unwanted hair and the results were at best temporary. Now, with the new longer wavelength, we can apply the deeper effects of the technology for hair removal, while bypassing the epidermal melanin present in dark-skinned individuals, explained Johnson, a general surgeon affiliated with Winthrop University Hospital in Mineola, N.Y.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024